Ligustroflavone

CAS No. 260413-62-5

Ligustroflavone ( Nuezhenoside )

Catalog No. M18322 CAS No. 260413-62-5

Ligustroflavone has anti-inflammatory activity.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 87 In Stock
10MG 147 In Stock
25MG 248 In Stock
50MG 357 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ligustroflavone
  • Note
    Research use only, not for human use.
  • Brief Description
    Ligustroflavone has anti-inflammatory activity.
  • Description
    Ligustroflavone has anti-inflammatory activity.
  • Synonyms
    Nuezhenoside
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    260413-62-5
  • Formula Weight
    724.67
  • Molecular Formula
    C33H40O18
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    c1(cc(=O)c2c(cc(cc2o1)O[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O[C@@H]1O[C@H]([C@@H]([C@H]([C@H]1O)O)O)C)O)O)CO[C@@H]1O[C@H]([C@@H]([C@H]([C@H]1O)O)O)C)O)c1ccc(cc1)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Pieroni A,et al. Isolation and structure elucidation of ligustroflavone, a new apigenin triglycoside from the leaves of Ligustrum vulgare L. Pharmazie. 2000 Jan;55(1):78-80.
molnova catalog
related products
  • Magnolignan A

    Magnolignan A-2-O-beta-D-glucopyranoside has medium cytotoxic activity against HEp-2 and HepG2 cells, with IC(50) of 13.3 microM, and 46.4 microM, respectively.

  • GPRP acetate

    GPRP acetate is fibrinogen-related peptides, which inhibit the interaction of fibrinogen with the platelet membrane glycoprotein IIbIIIa complex (GPIIbIIIa).

  • Syk Inhibitor II hyd...

    The impact of spleen tyrosine kinase (Syk) signaling might be prominent in lupus because (i) Syk is a shared downstream signaling molecule among circulating immune complex, LPS, and (1→3)-β-D-glucan (BG), and (ii) all of these factors are detectable in the serum of Fc gamma receptor IIb-deficient (FcgRIIb-/-) mice with sepsis. Syk inhibition downregulated several inflammatory pathways in FcgRIIb-/- macrophages activated with BG + LPS suggesting the potential anti-inflammatory impact of Syk inhibitors in lupus.